Citations for
1CHMP2B, FBXO32
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy.
Zaglia T, Milan G, Ruhs A, Franzoso M, Bertaggia E, Pianca N, Carpi A, Carullo P, Pesce P, Sacerdoti D, Sarais C, Catalucci D, Krüger M, Mongillo M, Sandri M.
J Clin Invest 124(6):2410-24. doi: 10.1172/JCI66339. Epub 2014 May 1. 2014
2FBXO32, TRIM63
Atrogin-1, MuRF-1, and sarcopenia.
Gumucio JP, Mendias CL.
Endocrine 43(1):12-21. doi: 10.1007/s12020-012-9751-7. Epub 2012 Jul 20. Review. 2013
3EIF3F, FBXO32
eIF3f: a central regulator of the antagonism atrophy/hypertrophy in skeletal muscle.
Sanchez AM, Csibi A, Raibon A, Docquier A, Lagirand-Cantaloube J, Leibovitch MP, Leibovitch SA, Bernardi H.
Int J Biochem Cell Biol 45(10):2158-62. doi: 10.1016/j.biocel.2013.06.001. Epub 2013 Jun 13. 2013
4FBXO32
Identification of essential sequences for cellular localization in the muscle-specific ubiquitin E3 ligase MAFbx/Atrogin 1.
Julie LC, Sabrina BP, Marie-Pierre L, Leibovitch SA.
FEBS Lett 586(4):362-7. doi: 10.1016/j.febslet.2011.12.031. Epub 2012 Jan 11. 2012
5DES, FBXO32, MSTN, VIM
Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting.
Lokireddy S, Wijesoma IW, Sze SK, McFarlane C, Kambadur R, Sharma M.
Am J Physiol Cell Physiol 303(5):C512-29. doi: 10.1152/ajpcell.00402.2011. Epub 2012 Jun 6. 2012
6FBXO32, TRIM63
Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats.
Maki T, Yamamoto D, Nakanishi S, Iida K, Iguchi G, Takahashi Y, Kaji H, Chihara K, Okimura Y.
Nutr Res 32(9):676-83. doi: 10.1016/j.nutres.2012.07.005. Epub 2012 Sep 17. 2012
7FBXO32, MSTN
Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S, McFarlane C, Ge X, Zhang H, Sze SK, Sharma M, Kambadur R.
Mol Endocrinol 25(11):1936-49. doi: 10.1210/me.2011-1124. Epub 2011 Sep 29. 2011
8FBXO32
Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells.
Li JJ, Zhang TP, Meng Y, Du J, Li HH.
Cell Physiol Biochem 27(5):463-70. doi: 10.1159/000329967. Epub 2011 Jun 15. 2011
9FBXO32
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.
Chou JL, Su HY, Chen LY, Liao YP, Hartman-Frey C, Lai YH, Yang HW, Deatherage DE, Kuo CT, Huang YW, Yan PS, Hsiao SH, Tai CK, Lin HJ, Davuluri RV, Chao TK, Nephew KP, Huang TH, Lai HC, Chan MW.
Lab Invest 90(3):414-25. doi: 10.1038/labinvest.2009.138. Epub 2010 Jan 11. 2010
10FBXO32
Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine.
Wang H, Liu D, Cao P, Lecker S, Hu Z.
Diabetes 59(8):1879-89. doi: 10.2337/db10-0207. Epub 2010 Jun 3. 2010
11FBXO32, TRIM63
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms.
Mearini G, Gedicke C, Schlossarek S, Witt CC, Krämer E, Cao P, Gomes MD, Lecker SH, Labeit S, Willis MS, Eschenhagen T, Carrier L.
Cardiovasc Res 85(2):357-66. doi: 10.1093/cvr/cvp348. Epub 2009 Oct 22. 2010
12FBXO32, MYOG
Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase.
Jogo M, Shiraishi S, Tamura TA.
FEBS Lett 583(17):2715-9. doi: 10.1016/j.febslet.2009.07.033. Epub 2009 Jul 22. 2009
13FBXO32, MYOD1
Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.
Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA.
PLoS One 4(3):e4973. doi: 10.1371/journal.pone.0004973. Epub 2009 Mar 25. 2009
14EIF3F, FBXO32
MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines.
Csibi A, Leibovitch MP, Cornille K, Tintignac LA, Leibovitch SA.
J Biol Chem 284(7):4413-21. doi: 10.1074/jbc.M807641200. Epub 2008 Dec 10. 2009
15FBXO32, MYOD1
Decreased muscle atrophy F-box (MAFbx) expression in regenerating muscle after muscle-damaging exercise.
Okada A, Ono Y, Nagatomi R, Kishimoto KN, Itoi E.
Muscle Nerve 38(4):1246-53. doi: 10.1002/mus.21110. 2008
16FBXO32
Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone.
Zhao W, Pan J, Wang X, Wu Y, Bauman WA, Cardozo CP.
Endocrinology 149(11):5449-60. doi: 10.1210/en.2008-0664. Epub 2008 Jul 3. 2008
17FBXO32
Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
Li HH, Willis MS, Lockyer P, Miller N, McDonough H, Glass DJ, Patterson C.
J Clin Invest 117(11):3211-23. 2007
18FBXO25, FBXO32
FBXO25, an F-box protein homologue of atrogin-1, is not induced in atrophying muscle.
Maragno AL, Baqui MM, Gomes MD.
Biochim Biophys Acta 1760(6):966-72. Epub 2006 Apr 4. 2006
19FOXO3, FBXO32
The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M, Sato K, Zeng L, Schiekofer S, Pimentel D, Lecker S, Taegtmeyer H, Goldberg AL, Walsh K.
J Biol Chem 280(21):20814-23. Epub 2005 Mar 21. 2005
20FBXO32
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C.
J Clin Invest 114(8):1058-71. 2004
21FBXO32, TRIM63
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ.
Science 294(5547):1704-8. 2001
22FBXO32
Atrogin-1, a muscle-specific F-box protein highly expressed during muscleatrophy.
Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL.
Proc Natl Acad Sci U S A 98(25):14440-5. 2001